Onconova Therapeutics Inc. (NASDAQ: ONTX) flaunted slowness of -4.59% at $1.56, as the Stock market unbolted on February 22, 2021. During the day, the stock rose to $1.69 and sunk to $1.50 before settling in for the price of $1.63 at the close. Taking a more long-term approach, ONTX posted a 52-week range of $0.19-$1.93.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 22.20%. Meanwhile, its Annual Earning per share during the time was 67.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 70.00%. This publicly-traded company’s shares outstanding now amounts to $180.88 million, simultaneously with a float of $173.37 million. The organization now has a market capitalization sitting at $351.89 million. At the time of writing, stock’s 50-day Moving Average stood at $0.7411, while the 200-day Moving Average is $0.5532.
If we measure the efficiency of the company that is accounted for 25 employees. It has generated 114,895 per worker during the last fiscal year. Meanwhile, its income per employee was -1,131,737. The stock had 32.83 Receivables turnover and 0.10 Total Asset turnover. For the Profitability, stocks operating margin was -994.00 and Pretax Margin of -984.56.
Onconova Therapeutics Inc. (ONTX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Onconova Therapeutics Inc. industry. Onconova Therapeutics Inc.’s current insider ownership accounts for 0.40%, in contrast to 10.70% institutional ownership. According to the most recent insider trade that took place on Feb 16, this organization’s SVP Corp Dev & Gen Counsel bought 12,000 shares at the rate of 1.00, making the entire transaction reach 12,000 in total value, affecting insider ownership by 152,000. Preceding that transaction, on Feb 16, Company’s Chief Financial Officer bought 15,000 for 1.00, making the whole transaction’s value amount to 15,000. This particular insider is now the holder of 145,213 in total.
Onconova Therapeutics Inc. (ONTX) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2020, it has been observed that the corporation posted -$0.03 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.03) by $0. This company achieved a net margin of -985.02 while generating a return on equity of -253.56. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Onconova Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 70.00% and is forecasted to reach -0.14 in the upcoming year.
Onconova Therapeutics Inc. (NASDAQ: ONTX) Trading Performance Indicators
Let’s observe the current performance indicators for Onconova Therapeutics Inc. (ONTX). It’s Quick Ratio in the last reported quarter now stands at 2.70. The Stock has managed to achieve an average true range (ATR) of 0.20. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1759.45.
In the same vein, ONTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.26, a figure that is expected to reach -0.03 in the next quarter, and analysts are predicting that it will be -0.14 at the market close of one year from today.
Technical Analysis of Onconova Therapeutics Inc. (ONTX)
Now, what If we examine the latest scores posted by [Onconova Therapeutics Inc., ONTX]. During the last 5-days, its volume was better the volume of 72.67 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 70.78% While, its Average True Range was 0.2351.
Raw Stochastic average of Onconova Therapeutics Inc. (ONTX) in the period of the previous 100 days is set at 78.11%, which indicates a major rise in contrast to 70.75% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 159.50% that was higher than 154.91% volatility it exhibited in the past 100-days period.